• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于天然和合成凝胶的胆汁酸螯合剂

Bile Acid Sequestrants Based on Natural and Synthetic Gels.

作者信息

Stanciu Magdalena-Cristina, Nichifor Marieta, Teacă Carmen-Alice

机构信息

Natural Polymers, Bioactive and Biocompatible Materials Department, "Petru Poni" Institute of Macromolecular Chemistry, 41A, Gr. Ghica-Voda Alley, 700487 Iasi, Romania.

Center for Advanced Research in Bionanoconjugates and Biopolymers, "Petru Poni" Institute of Macromolecular Chemistry, 41A, Gr. Ghica-Voda Alley, 700487 Iasi, Romania.

出版信息

Gels. 2023 Jun 19;9(6):500. doi: 10.3390/gels9060500.

DOI:10.3390/gels9060500
PMID:37367171
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10298123/
Abstract

Bile acid sequestrants (BASs) are non-systemic therapeutic agents used for the management of hypercholesterolemia. They are generally safe and not associated with serious systemic adverse effects. Usually, BASs are cationic polymeric gels that have the ability to bind bile salts in the small intestine and eliminate them by excretion of the non-absorbable polymer-bile salt complex. This review gives a general presentation of bile acids and the characteristics and mechanisms of action of BASs. The chemical structures and methods of synthesis are shown for commercial BASs of first- (cholestyramine, colextran, and colestipol) and second-generation (colesevelam and colestilan) and potential BASs. The latter are based on either synthetic polymers such as poly((meth)acrylates/acrylamides), poly(alkylamines), poly(allylamines) and vinyl benzyl amino polymers or biopolymers, such as cellulose, dextran, pullulan, methylan, and poly(cyclodextrins). A separate section is dedicated to molecular imprinting polymers (MIPs) because of their great selectivity and affinity for the template molecules used in the imprinting technique. Focus is given to the understanding of the relationships between the chemical structure of these cross-linked polymers and their potential to bind bile salts. The synthetic pathways used in obtaining BASs and their in vitro and in vivo hypolipidemic activities are also introduced.

摘要

胆汁酸螯合剂(BASs)是用于治疗高胆固醇血症的非全身性治疗药物。它们通常安全,且不伴有严重的全身性不良反应。通常,BASs是阳离子聚合物凝胶,能够在小肠中结合胆汁盐,并通过排泄不可吸收的聚合物 - 胆汁盐复合物将其清除。本综述概述了胆汁酸以及BASs的特性和作用机制。展示了第一代(考来烯胺、共聚维酮和考来替泊)和第二代(考来维仑和考来替兰)商用BASs以及潜在BASs的化学结构和合成方法。后者基于合成聚合物,如聚((甲基)丙烯酸酯/丙烯酰胺)、聚(烷基胺)、聚(烯丙胺)和乙烯基苄基氨基聚合物,或生物聚合物,如纤维素、葡聚糖、支链淀粉、甲基纤维素和聚(环糊精)。由于分子印迹聚合物(MIPs)对印迹技术中使用的模板分子具有高度的选择性和亲和力,因此专门用一个章节进行介绍。重点在于理解这些交联聚合物的化学结构与其结合胆汁盐的潜力之间的关系。还介绍了制备BASs所采用的合成途径及其体外和体内的降血脂活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/de69ebb79e9c/gels-09-00500-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/6d4b395d6238/gels-09-00500-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/1a92f51e9e6e/gels-09-00500-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/41d60be5da34/gels-09-00500-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/5721fb430a2c/gels-09-00500-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/ffb3095a0295/gels-09-00500-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/5fd15a15613b/gels-09-00500-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/950320ab022b/gels-09-00500-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/9a7cb0639d5e/gels-09-00500-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/5d70a30e1919/gels-09-00500-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/09f394e8fe16/gels-09-00500-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/80bc809978ce/gels-09-00500-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/de1ecb5b7913/gels-09-00500-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/9eafa62b605a/gels-09-00500-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/f51edc0a4ad8/gels-09-00500-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/86ec19ec3f7e/gels-09-00500-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/2bb6e66395e0/gels-09-00500-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/2cab3f986792/gels-09-00500-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/f42df6f97c0c/gels-09-00500-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/de69ebb79e9c/gels-09-00500-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/6d4b395d6238/gels-09-00500-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/1a92f51e9e6e/gels-09-00500-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/41d60be5da34/gels-09-00500-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/5721fb430a2c/gels-09-00500-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/ffb3095a0295/gels-09-00500-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/5fd15a15613b/gels-09-00500-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/950320ab022b/gels-09-00500-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/9a7cb0639d5e/gels-09-00500-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/5d70a30e1919/gels-09-00500-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/09f394e8fe16/gels-09-00500-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/80bc809978ce/gels-09-00500-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/de1ecb5b7913/gels-09-00500-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/9eafa62b605a/gels-09-00500-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/f51edc0a4ad8/gels-09-00500-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/86ec19ec3f7e/gels-09-00500-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/2bb6e66395e0/gels-09-00500-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/2cab3f986792/gels-09-00500-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/f42df6f97c0c/gels-09-00500-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c59/10298123/de69ebb79e9c/gels-09-00500-g017.jpg

相似文献

1
Bile Acid Sequestrants Based on Natural and Synthetic Gels.基于天然和合成凝胶的胆汁酸螯合剂
Gels. 2023 Jun 19;9(6):500. doi: 10.3390/gels9060500.
2
Polymeric bile acid sequestrants: Review of design, in vitro binding activities, and hypocholesterolemic effects.聚合型胆汁酸螯合剂:设计、体外结合活性及降胆固醇作用综述
Eur J Med Chem. 2018 Jan 20;144:300-317. doi: 10.1016/j.ejmech.2017.12.015. Epub 2017 Dec 6.
3
Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review.胆汁酸螯合剂在血脂异常治疗中的临床应用:一项科学综述。
South Med J. 2006 Mar;99(3):257-73. doi: 10.1097/01.smj.0000208120.73327.db.
4
Colesevelam hydrochloride.盐酸考来维仑
Am J Health Syst Pharm. 2002 May 15;59(10):932-9. doi: 10.1093/ajhp/59.10.932.
5
Use and indications of cholestyramine and bile acid sequestrants.考来烯胺和胆汁酸螯合剂的用途和适应证。
Intern Emerg Med. 2013 Apr;8(3):205-10. doi: 10.1007/s11739-011-0653-0. Epub 2011 Jul 8.
6
Efficacy of Bile Acid Sequestrants in the Treatment of Bile Acid Diarrhea: A Meta-Analysis of Randomized Controlled Trials.胆汁酸螯合剂治疗胆汁酸腹泻的疗效:一项随机对照试验的荟萃分析
J Clin Pharmacol. 2025 Apr;65(4):478-485. doi: 10.1002/jcph.6154. Epub 2024 Oct 21.
7
Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives.使用可持续生物聚合物治疗高胆固醇血症的胆汁酸螯合剂:最新进展与未来展望
Mol Pharm. 2022 May 2;19(5):1248-1272. doi: 10.1021/acs.molpharmaceut.2c00007. Epub 2022 Mar 25.
8
In vitro and in vivo evaluation of novel cross-linked saccharide based polymers as bile acid sequestrants.新型交联糖基聚合物作为胆汁酸螯合剂的体外和体内评价
Molecules. 2015 Feb 24;20(3):3716-29. doi: 10.3390/molecules20033716.
9
Bile acid sequestrants and the treatment of type 2 diabetes mellitus.胆汁酸螯合剂与2型糖尿病的治疗
Drugs. 2007;67(10):1383-92. doi: 10.2165/00003495-200767100-00001.
10
Bile acid sequestrants: a review of mechanism and design.胆汁酸螯合剂:作用机制与设计研究综述。
J Pharm Pharmacol. 2021 Jun 8;73(7):855-861. doi: 10.1093/jpp/rgab002.

引用本文的文献

1
The Application of Mesoporous Silica Nanoparticles in Enhancing the Efficacy of Anti-Atherosclerosis Therapies: A Review.介孔二氧化硅纳米颗粒在增强抗动脉粥样硬化治疗效果中的应用:综述
Int J Nanomedicine. 2025 Aug 10;20:9825-9856. doi: 10.2147/IJN.S538100. eCollection 2025.
2
Update of safety profile of bile acid sequestrants: A real-world pharmacovigilance study of the FDA adverse event reporting system.胆汁酸螯合剂安全性概况更新:一项关于美国食品药品监督管理局不良事件报告系统的真实世界药物警戒研究
PLoS One. 2025 Jul 15;20(7):e0328371. doi: 10.1371/journal.pone.0328371. eCollection 2025.
3
Role of Arthrospira Platensis in Preventing and Treating High-Fat Diet-Induced Hypercholesterolemia in Adult Rats.

本文引用的文献

1
Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing.胆酸螯合剂在显微镜下结肠炎中的应用:胆酸检测的临床结果和实用性。
Clin Gastroenterol Hepatol. 2023 Nov;21(12):3125-3131.e2. doi: 10.1016/j.cgh.2023.04.031. Epub 2023 May 10.
2
Insights on Some Polysaccharide Gel Type Materials and Their Structural Peculiarities.关于一些多糖凝胶类材料及其结构特性的见解。
Gels. 2022 Nov 26;8(12):771. doi: 10.3390/gels8120771.
3
Bile Acids: Physiological Activity and Perspectives of Using in Clinical and Laboratory Diagnostics.
螺旋藻在预防和治疗成年大鼠高脂饮食诱导的高胆固醇血症中的作用。
Nutrients. 2024 Jun 11;16(12):1827. doi: 10.3390/nu16121827.
4
The Effects of Aflatoxin B on Liver Cholestasis and Its Nutritional Regulation in Ducks.黄曲霉毒素 B 对鸭肝脏胆汁淤积的影响及其营养调控。
Toxins (Basel). 2024 May 24;16(6):239. doi: 10.3390/toxins16060239.
5
Lipid-Derived Biomarkers as Therapeutic Targets for Chronic Coronary Syndrome and Ischemic Stroke: An Updated Narrative Review.脂质衍生生物标志物作为慢性冠状动脉综合征和缺血性中风的治疗靶点:最新叙述性综述
Medicina (Kaunas). 2024 Mar 29;60(4):561. doi: 10.3390/medicina60040561.
6
Bile Acid Diarrhea: From Molecular Mechanisms to Clinical Diagnosis and Treatment in the Era of Precision Medicine.胆汁酸腹泻:精准医学时代的分子机制到临床诊断与治疗。
Int J Mol Sci. 2024 Jan 26;25(3):1544. doi: 10.3390/ijms25031544.
胆汁酸:生理活性及在临床与实验室诊断中的应用展望。
Molecules. 2022 Nov 13;27(22):7830. doi: 10.3390/molecules27227830.
4
Colesevelam - a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia.考来烯胺——一种用于治疗高胆固醇血症和改善高血糖的胆汁酸螯合剂。
Expert Opin Pharmacother. 2022 Aug;23(12):1363-1370. doi: 10.1080/14656566.2022.2112945. Epub 2022 Aug 22.
5
Lipid Lowering Therapy: An Era Beyond Statins.降脂治疗:超越他汀类药物的时代。
Curr Probl Cardiol. 2022 Dec;47(12):101342. doi: 10.1016/j.cpcardiol.2022.101342. Epub 2022 Jul 31.
6
The impact of treatment with bile acid sequestrants on quality of life in patients with bile acid diarrhoea.胆汁酸螯合剂治疗对胆汁酸腹泻患者生活质量的影响。
BMC Gastroenterol. 2022 Jul 2;22(1):325. doi: 10.1186/s12876-022-02404-9.
7
Undertreatment or Overtreatment With Statins: Where Are We?他汀类药物治疗不足或过度治疗:我们目前的状况如何?
Front Cardiovasc Med. 2022 Apr 29;9:808712. doi: 10.3389/fcvm.2022.808712. eCollection 2022.
8
Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives.使用可持续生物聚合物治疗高胆固醇血症的胆汁酸螯合剂:最新进展与未来展望
Mol Pharm. 2022 May 2;19(5):1248-1272. doi: 10.1021/acs.molpharmaceut.2c00007. Epub 2022 Mar 25.
9
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice.考来烯胺可改善非酒精性脂肪性肝炎和肥胖症小鼠的病情。
Hepatol Int. 2022 Apr;16(2):359-370. doi: 10.1007/s12072-022-10296-w. Epub 2022 Jan 24.
10
Bigels as drug delivery systems: From their components to their applications.作为药物递送系统的水凝胶:从其组成部分到应用。
Drug Discov Today. 2022 Apr;27(4):1008-1026. doi: 10.1016/j.drudis.2021.12.011. Epub 2021 Dec 20.